SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-233290
Filing Date
2021-08-02
Accepted
2021-08-02 16:21:04
Documents
3
Period of Report
2021-08-02
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d202084d8k.htm 8-K 20712
2 EX-3.1 d202084dex31.htm EX-3.1 37764
3 EX-3.2 d202084dex32.htm EX-3.2 179253
  Complete submission text file 0001193125-21-233290.txt   238909
Mailing Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102 (858) 775-4523
Icosavax, Inc. (Filer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40655 | Film No.: 211136298
SIC: 2836 Biological Products, (No Diagnostic Substances)